Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Organic Letters
|
May 7, 2004
Solid-phase synthesis of anandamide analogues
Longwu Qi, Michael M Meijler, Sang-Hyeup Lee, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 20, 2005
Quorum sensing in Vibrio harveyi: probing the specificity of the LuxP binding site
Colin A Lowery, Kathleen M McKenzie, Longwu Qi, et al.
Annals of the New York Academy of Sciences
|
October 3, 2009
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
Mini Thomas, Sumith A Kularatne, Longwu Qi, et al.
Journal of Medicinal Chemistry
|
November 11, 2005
Delta9-tetrahydrocannabinol immunochemical studies: haptens, monoclonal antibodies, and a convenient synthesis of radiolabeled delta9-tetrahydrocannabinol
Longwu Qi, Noboru Yamamoto, Michael M Meijler, et al.
Journal of Medicinal Chemistry
|
October 17, 2008
Prevention of drug-induced memory impairment by immunopharmacotherapy
Jennifer B Treweek, Chengzao Sun, Alexander V Mayorov, et al.
Journal of the American Chemical Society
|
February 24, 2005
Fluorescent cocaine probes: a tool for the selection and engineering of therapeutic antibodies
Michael M Meijler, Gunnar F Kaufmann, Longwu Qi, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Toward Orally Absorbed Prodrugs of the Antibiotic Aztreonam. Design of Novel Prodrugs of Sulfate Containing Drugs. Part 2
Eric M Gordon, Matthew A J Duncton, Brian J Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 8, 2020
Design and synthesis of a folate-receptor targeted diazepine-ring-opened pyrrolobenzodiazepine prodrug conjugate
Iontcho R Vlahov, Longwu Qi, Hari Krishna R Santhapuram, et al.
Bioconjugate Chemistry
|
December 7, 2017
Latent Warheads for Targeted Cancer Therapy: Design and Synthesis of pro-Pyrrolobenzodiazepines and Conjugates
Iontcho R Vlahov, Longwu Qi, Paul J Kleindl, et al.
Scientific Reports
|
July 31, 2020
Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agent
Joseph A Reddy, Melissa Nelson, Christina Dircksen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Organic Letters
|
May 7, 2004
Solid-phase synthesis of anandamide analogues
Longwu Qi, Michael M Meijler, Sang-Hyeup Lee, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 20, 2005
Quorum sensing in Vibrio harveyi: probing the specificity of the LuxP binding site
Colin A Lowery, Kathleen M McKenzie, Longwu Qi, et al.
Annals of the New York Academy of Sciences
|
October 3, 2009
Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues
Mini Thomas, Sumith A Kularatne, Longwu Qi, et al.
Journal of Medicinal Chemistry
|
November 11, 2005
Delta9-tetrahydrocannabinol immunochemical studies: haptens, monoclonal antibodies, and a convenient synthesis of radiolabeled delta9-tetrahydrocannabinol
Longwu Qi, Noboru Yamamoto, Michael M Meijler, et al.
Journal of Medicinal Chemistry
|
October 17, 2008
Prevention of drug-induced memory impairment by immunopharmacotherapy
Jennifer B Treweek, Chengzao Sun, Alexander V Mayorov, et al.
Journal of the American Chemical Society
|
February 24, 2005
Fluorescent cocaine probes: a tool for the selection and engineering of therapeutic antibodies
Michael M Meijler, Gunnar F Kaufmann, Longwu Qi, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Toward Orally Absorbed Prodrugs of the Antibiotic Aztreonam. Design of Novel Prodrugs of Sulfate Containing Drugs. Part 2
Eric M Gordon, Matthew A J Duncton, Brian J Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 8, 2020
Design and synthesis of a folate-receptor targeted diazepine-ring-opened pyrrolobenzodiazepine prodrug conjugate
Iontcho R Vlahov, Longwu Qi, Hari Krishna R Santhapuram, et al.
Bioconjugate Chemistry
|
December 7, 2017
Latent Warheads for Targeted Cancer Therapy: Design and Synthesis of pro-Pyrrolobenzodiazepines and Conjugates
Iontcho R Vlahov, Longwu Qi, Paul J Kleindl, et al.
Scientific Reports
|
July 31, 2020
Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agent
Joseph A Reddy, Melissa Nelson, Christina Dircksen, et al.
Page
of 1